申请人:AJINOMOTO CO., INC.
                            
                            
                                公开号:US20020133005A1
                            
                            
                                公开(公告)日:2002-09-19
                            
                            The present invention provides an AP-1 activation inhibitor, a NF-kappaB activation inhibitor, an inflammatory cytokine production inhibitor, a production inhibitor for matrix metalloprotease or an inflammatory cell adhesion factor expression inhibitor, which contains a heterocyclic compound or a pharmaceutically acceptable salt thereof as an active ingredient.
                            本发明提供了一种AP-1激活
抑制剂、一种NF-kappaB激活
抑制剂、一种炎症细胞因子产生
抑制剂、一种基质
金属
蛋白酶产生
抑制剂或一种炎症细胞黏附因子表达
抑制剂,其包含一种
杂环化合物或其药用可接受的盐作为活性成分。